Daiichi Sankyo
Jinma Ren serves as the Senior Director and Head of Epidemiology Analytics at Daiichi Sankyo US since April 2024, where responsibilities include leading the Epidemiology analytics team and collaborating with cross-functional teams on safety data generation and evaluation. Previously, Jinma held the position of Director of Biostatistics at Pfizer from November 2020 to April 2024 and was a Senior Manager at Atara Biotherapeutics between October 2019 and November 2020. Prior experience includes serving as a Research Associate Professor, Research Assistant Professor, and Research Specialist at the University of Illinois College of Medicine at Peoria from June 2012 to October 2019, as well as working as Program Manager and Associate Chief Physician at the Shanghai Municipal Center for Disease Control and Prevention from July 2007 to May 2012, focusing on HIV/AIDS control and prevention. Jinma holds a Ph.D. in Epidemiology and Health Statistics from the Chinese Center for Disease Control and Prevention, a Master's Degree in Epidemiology and Health Statistics, and a Bachelor's Degree in Preventive Medicine from Nantong University.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.